Glaxo Wellcome earmarks more for research

Pharmaceutical giant Glaxo Wellcome spent Pounds 1.15 billion on research and development in 1997, according to its annual report. The firm, which notched up global sales worth Pounds 8 billion, says it expects to spend Pounds 1.2 billion on R&D next year. It says that for the pharmaceutical industry worldwide, sales in 1997 were up 9 per cent to Pounds 166 billion.The North American market saw the greatest increase from 9 per cent growth in 1996 to 15 per cent in 1997, generating Pounds 61 billion of sales.

The United States accounts for 35 per cent of the global market. Europe has experienced a decline in growth from 9 per cent to 6 per cent. Growth in Latin America has increased from 7 per cent to 11 per cent, while in Asia Pacific growth has slowed from 13 per cent to 9 per cent.

Already registered?

Sign in now if you are already registered or a current subscriber. Or subscribe for unrestricted access to our digital editions and iPad and iPhone app.

Register to continue  

You've enjoyed reading five THE articles this month. Register now to get five more, or subscribe for unrestricted access.

Most Commented

  • Man measuring bar graphs with tape measure

An Elsevier analysis explores the viability of a ‘smarter and cheaper’ model

  • David Willetts

The former universities minister discusses the reforms that reshaped higher education and his first steps into academia

  • Man holding a box filled with work-related items

Refusal by John Allen to obey instruction from manager at Queen Mary University of London led to his sacking, tribunal rules

  • A black and white crowd scene with a few people highlighted

What are the key issues local union branches are dealing with, and how do they manage relationships with institutions in what many activists argue is an increasingly confrontational environment?

  • Muslim woman at graduation ceremony, Barbican, London

Sector called on to embrace faith-related concerns in intellectual debates